Phosphatidylinositol_NN
3-kinase_NN
couples_VBZ
the_DT
interleukin-2_NN
receptor_NN
to_TO
the_DT
cell_NN
cycle_NN
regulator_NN
E2F_NN
._.

Cell_NN
cycle_NN
progression_NN
initiated_VBN
by_IN
interleukin-2_NN
-LRB-_-LRB-
IL-2_NN
-RRB-_-RRB-
in_IN
T_NN
cells_NNS
is_VBZ
critical_JJ
for_IN
lymphoproliferation_NN
and_CC
an_DT
immune_JJ
response_NN
._.

Phosphatidyl_NN
inositol_NN
3-kinase_NN
-LRB-_-LRB-
PI3K_NN
-RRB-_-RRB-
is_VBZ
activated_VBN
by_IN
IL-2_NN
._.

However_RB
,_,
nuclear_JJ
targets_NNS
for_IN
PI3K_NN
are_VBP
not_RB
known_VBN
._.

Here_RB
we_PRP
identify_VBP
the_DT
cell_NN
cycle_NN
regulator_NN
E2F_NN
as_IN
an_DT
IL-2_NN
target_NN
in_IN
T_NN
lymphocytes_NNS
and_CC
PI3K_NN
as_IN
the_DT
critical_JJ
signaling_NN
pathway_NN
._.

We_PRP
eliminate_VBP
both_CC
Stat5_NN
and_CC
Raf\/MEK_NN
pathways_NNS
from_IN
E2F_NN
regulation_NN
._.

Protein_NN
kinase_NN
B_NN
-LRB-_-LRB-
PKB_NN
-RRB-_-RRB-
is_VBZ
activated_VBN
by_IN
IL-2_NN
via_IN
PI3K_NN
._.

The_DT
expression_NN
of_IN
an_DT
active_JJ
PKB_NN
is_VBZ
sufficient_JJ
to_TO
induce_VB
E2F_NN
activity_NN
._.

Inhibition_NN
of_IN
PI3K_NN
inhibits_VBZ
phosphorylation_NN
of_IN
Rb_NN
,_,
induction_NN
of_IN
cyclin_NN
D3_NN
,_,
and_CC
degradation_NN
of_IN
p27kip1_NN
._.

These_DT
results_NNS
establish_VBP
a_DT
crucial_JJ
PI3K\/PKB-mediated_JJ
link_NN
between_IN
the_DT
IL-2_NN
teceptor_NN
and_CC
the_DT
cell_NN
cycle_NN
machinery_NN
._.

